Robert Nelsen - Director, 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Nelsen since 25 May 2025

Holdings reported by Robert Nelsen for Lyell Immunopharma, Inc.

Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class
Common Stock
Shares / value
18,206,358
Estimated value
$41,510,496
Report date
14 Jun 2024
Price
$2.28
Ownership
ARCH Venture Fund IX,L.P.
Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class
Common Stock
Shares / value
18,206,358
Estimated value
$41,510,496
Report date
14 Jun 2024
Price
$2.28
Ownership
ARCH Venture Fund IX Overage, L.P.
Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class
Option (right to buy)
Shares / value
130,000
Estimated value
Report date
14 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Robert Nelsen for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .